Analysis of tumor DNA in GPR161 germline mutation carriers revealed LOH at the GPR161 locus, unexceptionally leading to loss of the wild-type allele in all affected patients (P = .03, n = 6, binomial test; Fig 2B and Data Supplement). Here, GPR161 is linked to neoplasm.